Verition Fund Management’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-185,179
| Closed | -$4.47M | – | 3109 |
|
|
2025
Q1 | $4.47M | Buy |
185,179
+158,838
| +603% | +$3.84M | 0.02% | 806 |
|
|
2024
Q4 | $1.06M | Buy |
26,341
+18,620
| +241% | +$749K | ﹤0.01% | 1499 |
|
|
2024
Q3 | $489K | Buy |
7,721
+3,446
| +81% | +$218K | ﹤0.01% | 1703 |
|
|
2024
Q2 | $227K | Sell |
4,275
-5,376
| -56% | -$285K | ﹤0.01% | 1883 |
|
|
2024
Q1 | $791K | Buy |
+9,651
| New | +$791K | 0.01% | 1249 |
|
|
2023
Q2 | – | Sell |
-73,443
| Closed | -$1.22M | – | 2277 |
|
|
2023
Q1 | $1.22M | Buy |
+73,443
| New | +$1.22M | 0.02% | 790 |
|
|
2019
Q4 | – | Sell |
-109,117
| Closed | -$751K | – | 1232 |
|
|
2019
Q3 | $751K | Sell |
109,117
-64,183
| -37% | -$442K | 0.02% | 394 |
|
|
2019
Q2 | $1.44M | Buy |
173,300
+162,960
| +1,576% | +$1.35M | 0.04% | 258 |
|
|
2019
Q1 | $103K | Buy |
+10,340
| New | +$103K | ﹤0.01% | 952 |
|
|
2018
Q2 | – | Sell |
-11,546
| Closed | -$50K | – | 1261 |
|
|
2018
Q1 | $50K | Buy |
+11,546
| New | +$50K | ﹤0.01% | 1024 |
|